Erpolat, O. Et Al. 2014. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study. European Journal of Gynaecological Oncology , vol.35, no.1 , 62-66.

Erpolat, O., Alco, G., Caglar, H., Igdem, S., Saran, A., Dagoglu, N., ... Aslay, I.(2014). Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study. European Journal of Gynaecological Oncology , vol.35, no.1, 62-66.

Erpolat, O.P. Et Al. "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study," European Journal of Gynaecological Oncology , vol.35, no.1, 62-66, 2014

Erpolat, O.P. Et Al. "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study." European Journal of Gynaecological Oncology , vol.35, no.1, pp.62-66, 2014

Erpolat, O. Et Al. (2014) . "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study." European Journal of Gynaecological Oncology , vol.35, no.1, pp.62-66.

@article{article, author={O.P. Erpolat Et Al. }, title={Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: A national multi-center study}, journal={European Journal of Gynaecological Oncology}, year=2014, pages={62-66} }